BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 30651001)

  • 1. PI3Kγ (Phosphoinositide 3-Kinase γ) Regulates Vascular Smooth Muscle Cell Phenotypic Modulation and Neointimal Formation Through CREB (Cyclic AMP-Response Element Binding Protein)/YAP (Yes-Associated Protein) Signaling.
    Yu Q; Li W; Jin R; Yu S; Xie D; Zheng X; Zhong W; Cheng X; Hu S; Li M; Zheng Q; Li G; Song Z
    Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):e91-e105. PubMed ID: 30651001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3Kγ promotes vascular smooth muscle cell phenotypic modulation and transplant arteriosclerosis via a SOX9-dependent mechanism.
    Yu Q; Li W; Xie D; Zheng X; Huang T; Xue P; Guo B; Gao Y; Zhang C; Sun P; Li M; Wang G; Cheng X; Zheng Q; Song Z
    EBioMedicine; 2018 Oct; 36():39-53. PubMed ID: 30241919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The induction of yes-associated protein expression after arterial injury is crucial for smooth muscle phenotypic modulation and neointima formation.
    Wang X; Hu G; Gao X; Wang Y; Zhang W; Harmon EY; Zhi X; Xu Z; Lennartz MR; Barroso M; Trebak M; Chen C; Zhou J
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2662-9. PubMed ID: 22922963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.
    Wu H; Cheng XW; Hu L; Takeshita K; Hu C; Du Q; Li X; Zhu E; Huang Z; Yisireyili M; Zhao G; Piao L; Inoue A; Jiang H; Lei Y; Zhang X; Liu S; Dai Q; Kuzuya M; Shi GP; Murohara T
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1549-57. PubMed ID: 27365406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of yes-associated protein (YAP) specifically in cardiac and vascular smooth muscle cells reveals a crucial role for YAP in mouse cardiovascular development.
    Wang Y; Hu G; Liu F; Wang X; Wu M; Schwarz JJ; Zhou J
    Circ Res; 2014 Mar; 114(6):957-65. PubMed ID: 24478334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine monophosphate-activated protein kinase-α2 deficiency promotes vascular smooth muscle cell migration via S-phase kinase-associated protein 2 upregulation and E-cadherin downregulation.
    Song P; Zhou Y; Coughlan KA; Dai X; Xu H; Viollet B; Zou MH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2800-9. PubMed ID: 24115035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BubR1 insufficiency inhibits neointimal hyperplasia through impaired vascular smooth muscle cell proliferation in mice.
    Kyuragi R; Matsumoto T; Harada Y; Saito S; Onimaru M; Nakatsu Y; Tsuzuki T; Nomura M; Yonemitsu Y; Maehara Y
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):341-7. PubMed ID: 25524773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA-SRA promotes neointimal hyperplasia and vascular smooth muscle cells proliferation via MEK-ERK-CREB pathway.
    Zhang CJ; Liu C; Wang YX; Zhu N; Hu ZY; Liao DF; Qin L
    Vascul Pharmacol; 2019 May; 116():16-23. PubMed ID: 30822571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salt-Inducible Kinase 3 Promotes Vascular Smooth Muscle Cell Proliferation and Arterial Restenosis by Regulating AKT and PKA-CREB Signaling.
    Cai Y; Wang XL; Lu J; Lin X; Dong J; Guzman RJ
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2431-2451. PubMed ID: 34196217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation.
    Li P; Zhu N; Yi B; Wang N; Chen M; You X; Zhao X; Solomides CC; Qin Y; Sun J
    Circ Res; 2013 Oct; 113(10):1117-27. PubMed ID: 24014830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
    Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis repressor with caspase recruitment domain promotes cell proliferation and phenotypic modulation through 14-3-3ε/YAP signaling in vascular smooth muscle cells.
    Liu M; Yu T; Li M; Fang X; Hou B; Liu G; Wang J
    J Mol Cell Cardiol; 2020 Oct; 147():35-48. PubMed ID: 32771410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
    Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia.
    Serrano RL; Yu W; Graham RM; Bryan RL; Terkeltaub R
    PLoS One; 2019; 14(4):e0212235. PubMed ID: 30943188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Pathological Role of hnRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) in Vascular Smooth Muscle Cell Function and Neointima Hyperplasia.
    Zhang L; Chen Q; An W; Yang F; Maguire EM; Chen D; Zhang C; Wen G; Yang M; Dai B; Luong LA; Zhu J; Xu Q; Xiao Q
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2182-2194. PubMed ID: 28912364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.
    Cai Y; Nagel DJ; Zhou Q; Cygnar KD; Zhao H; Li F; Pi X; Knight PA; Yan C
    Circ Res; 2015 Mar; 116(7):1120-32. PubMed ID: 25608528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in Mice.
    Kiene LS; Homann S; Suvorava T; Rabausch B; Müller J; Kojda G; Kretschmer I; Twarock S; Dai G; Deenen R; Hartwig S; Lehr S; Köhrer K; Savani RC; Grandoch M; Fischer JW
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):e9-16. PubMed ID: 26586662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.